Cargando…

The G2 checkpoint—a node‐based molecular switch

Tight regulation of the eukaryotic cell cycle is paramount to ensure genomic integrity throughout life. Cell cycle checkpoints are present in each phase of the cell cycle and prevent cell cycle progression when genomic integrity is compromised. The G2 checkpoint is an intricate signaling network tha...

Descripción completa

Detalles Bibliográficos
Autores principales: de Gooijer, Mark C., van den Top, Arnout, Bockaj, Irena, Beijnen, Jos H., Würdinger, Thomas, van Tellingen, Olaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5377395/
https://www.ncbi.nlm.nih.gov/pubmed/28396830
http://dx.doi.org/10.1002/2211-5463.12206
_version_ 1782519308741509120
author de Gooijer, Mark C.
van den Top, Arnout
Bockaj, Irena
Beijnen, Jos H.
Würdinger, Thomas
van Tellingen, Olaf
author_facet de Gooijer, Mark C.
van den Top, Arnout
Bockaj, Irena
Beijnen, Jos H.
Würdinger, Thomas
van Tellingen, Olaf
author_sort de Gooijer, Mark C.
collection PubMed
description Tight regulation of the eukaryotic cell cycle is paramount to ensure genomic integrity throughout life. Cell cycle checkpoints are present in each phase of the cell cycle and prevent cell cycle progression when genomic integrity is compromised. The G2 checkpoint is an intricate signaling network that regulates the progression of G2 to mitosis (M). We propose here a node‐based model of G2 checkpoint regulation, in which the action of the central CDK1–cyclin B1 node is determined by the concerted but opposing activities of the Wee1 and cell division control protein 25C (CDC25C) nodes. Phosphorylation of both Wee1 and CDC25C at specific sites determines their subcellular localization, driving them either toward activity within the nucleus or to the cytoplasm and subsequent ubiquitin‐mediated proteasomal degradation. In turn, this subcellular balance of the Wee1 and CDC25C nodes is directed by the action of the PLK1 and CHK1 nodes via what we have termed the ‘nuclear and cytoplasmic decision states’ of Wee1 and CDC25C. The proposed node‐based model provides an intelligible structure of the complex interactions that govern the decision to delay or continue G2/M progression. The model may also aid in predicting the effects of agents that target these G2 checkpoint nodes.
format Online
Article
Text
id pubmed-5377395
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-53773952017-04-10 The G2 checkpoint—a node‐based molecular switch de Gooijer, Mark C. van den Top, Arnout Bockaj, Irena Beijnen, Jos H. Würdinger, Thomas van Tellingen, Olaf FEBS Open Bio Hypothesis Tight regulation of the eukaryotic cell cycle is paramount to ensure genomic integrity throughout life. Cell cycle checkpoints are present in each phase of the cell cycle and prevent cell cycle progression when genomic integrity is compromised. The G2 checkpoint is an intricate signaling network that regulates the progression of G2 to mitosis (M). We propose here a node‐based model of G2 checkpoint regulation, in which the action of the central CDK1–cyclin B1 node is determined by the concerted but opposing activities of the Wee1 and cell division control protein 25C (CDC25C) nodes. Phosphorylation of both Wee1 and CDC25C at specific sites determines their subcellular localization, driving them either toward activity within the nucleus or to the cytoplasm and subsequent ubiquitin‐mediated proteasomal degradation. In turn, this subcellular balance of the Wee1 and CDC25C nodes is directed by the action of the PLK1 and CHK1 nodes via what we have termed the ‘nuclear and cytoplasmic decision states’ of Wee1 and CDC25C. The proposed node‐based model provides an intelligible structure of the complex interactions that govern the decision to delay or continue G2/M progression. The model may also aid in predicting the effects of agents that target these G2 checkpoint nodes. John Wiley and Sons Inc. 2017-03-04 /pmc/articles/PMC5377395/ /pubmed/28396830 http://dx.doi.org/10.1002/2211-5463.12206 Text en © 2017 The Authors. Published by FEBS Press and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Hypothesis
de Gooijer, Mark C.
van den Top, Arnout
Bockaj, Irena
Beijnen, Jos H.
Würdinger, Thomas
van Tellingen, Olaf
The G2 checkpoint—a node‐based molecular switch
title The G2 checkpoint—a node‐based molecular switch
title_full The G2 checkpoint—a node‐based molecular switch
title_fullStr The G2 checkpoint—a node‐based molecular switch
title_full_unstemmed The G2 checkpoint—a node‐based molecular switch
title_short The G2 checkpoint—a node‐based molecular switch
title_sort g2 checkpoint—a node‐based molecular switch
topic Hypothesis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5377395/
https://www.ncbi.nlm.nih.gov/pubmed/28396830
http://dx.doi.org/10.1002/2211-5463.12206
work_keys_str_mv AT degooijermarkc theg2checkpointanodebasedmolecularswitch
AT vandentoparnout theg2checkpointanodebasedmolecularswitch
AT bockajirena theg2checkpointanodebasedmolecularswitch
AT beijnenjosh theg2checkpointanodebasedmolecularswitch
AT wurdingerthomas theg2checkpointanodebasedmolecularswitch
AT vantellingenolaf theg2checkpointanodebasedmolecularswitch
AT degooijermarkc g2checkpointanodebasedmolecularswitch
AT vandentoparnout g2checkpointanodebasedmolecularswitch
AT bockajirena g2checkpointanodebasedmolecularswitch
AT beijnenjosh g2checkpointanodebasedmolecularswitch
AT wurdingerthomas g2checkpointanodebasedmolecularswitch
AT vantellingenolaf g2checkpointanodebasedmolecularswitch